
    
      To determine the safety and validity of venous angioplasty and valvuloplasty in the treatment
      of CCSVI. In addition, it will allow researchers to sub-classify valve morphology in relation
      to treatment success. This will be evidenced by venous patency forty-eight hours by Doppler
      ultrasound as well as clinical symptom improvement.
    
  